VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

Why do we need biosimilars?

Paul Cornes, MD, University Hospital Bristol NHS Foundation Trust, Bristol, UK is one of the UK’s leading experts in biosimilars. Biologic treatments are allowing patients to live longer. Nowadays they can live for many years with some cancers, including chronic blood cancers. Understanding the cost of long-term treatment in cancer, helps us to appreciate how biosimilars could be part of the solution for affordable cancer care.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter